We are live on ! Find out more
FMTX

Forma Therapeutics Holdings, Inc. Common Stock
FMTX

Delisted

FMTX was delisted on the 13th of October, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in Forma Therapeutics Holdings, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 137 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 139 → 0 (-139)

100% less funds holding in top 10

Funds holding in top 10: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $835M → $0 (-$835M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 137

Holders
–
Holders Change
-139
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
137
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$180M
2
BlackRock
BlackRock
New York
-$72.5M
3
BBA
Baker Bros. Advisors
New York
-$37.6M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$37.2M
5
TAL
TIG Advisors LLC
New York
-$26.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
76
Barclays
United Kingdom
– -$871K -43,633 Closed
California State Teachers Retirement System (CalSTRS)
77
California State Teachers Retirement System (CalSTRS)
California
– -$859K -43,078 Closed
Skandinaviska Enskilda Banken (SEB)
78
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$828K -41,505 Closed
Tudor Investment Corp
79
Tudor Investment Corp
Connecticut
– -$698K -35,000 Closed
CANY
80
Caxton Associates (New York)
New York
– -$682K -34,190 Closed
State of Wisconsin Investment Board
81
State of Wisconsin Investment Board
Wisconsin
– -$677K -33,935 Closed
Allspring Global Investments
82
Allspring Global Investments
North Carolina
– -$604K -30,313 Closed
PP
83
PDT Partners
New York
– -$580K -29,063 Closed
TI
84
Trexquant Investment
Connecticut
– -$576K -28,868 Closed
Millennium Management
85
Millennium Management
New York
– -$531K -26,629 Closed
AA
86
ALPS Advisors
Colorado
– -$522K -26,147 Closed
Voloridge Investment Management
87
Voloridge Investment Management
Florida
– -$464K -23,254 Closed
New York State Common Retirement Fund
88
New York State Common Retirement Fund
New York
– -$460K -23,036 Closed
Mirae Asset Global Investments
89
Mirae Asset Global Investments
South Korea
– -$443K -22,198 Closed
GFP
90
Gryphon Financial Partners
Ohio
– -$379K -18,993 Closed
MIM
91
MetLife Investment Management
New Jersey
– -$377K -18,921 Closed
UBS AM
92
UBS AM
Illinois
– -$370K -18,528 Closed
CSS
93
Cubist Systematic Strategies
Connecticut
– -$343K -17,200 Closed
AIG
94
American International Group
New York
– -$343K -17,172 Closed
SFI
95
Susquehanna Fundamental Investments
Pennsylvania
– -$324K -16,218 Closed
D.E. Shaw & Co
96
D.E. Shaw & Co
New York
– -$319K -16,010 Closed
Manulife (Manufacturers Life Insurance)
97
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$307K -15,404 Closed
Deutsche Bank
98
Deutsche Bank
Germany
– -$302K -15,151 Closed
BNP Paribas Financial Markets
99
BNP Paribas Financial Markets
France
– -$301K -15,080 Closed
GC
100
Guggenheim Capital
Illinois
– -$280K -14,053 Closed
2 3
4
5 6

FMTX Hedge Fund Activity: Q4 2022 in Review

0 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Forma Therapeutics Holdings, Inc. Common Stock (FMTX) for Q4 2022, worth a combined $0 — down 100% from $835M a quarter earlier.

Sellers outnumbered buyers: 137 funds closed out of FMTX and 0 opened new positions — a net loss of 137 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RA Capital Management, exiting entirely with an estimated $180M sold.

  • 0 institutional investors held Forma Therapeutics Holdings, Inc. Common Stock (FMTX) as of Q4 2022, down from 139 in Q3 2022.
  • Funds reported $0 of Forma Therapeutics Holdings, Inc. Common Stock stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Forma Therapeutics Holdings, Inc. Common Stock positions in Q4 2022 and 137 closed out, a net change of -137 holders.
  • The largest Forma Therapeutics Holdings, Inc. Common Stock seller in Q4 2022 was RA Capital Management, an estimated $180M sold.

Based on aggregated 13F filings for Q4 2022.